Abstract
Interpretation of semen analysis (SA) results is an important skill for any clinician who cares for men with subfertility or testicular dysfunction. Confirmed SA abnormalities indicate the presence of male factor infertility, which occurs in 40–60% of subfertile couples, and guides subsequent evaluation and management. Male factor infertility is important to identify because it may be amenable to medical or surgical therapy, and because it may be the presenting symptom of occult health-threatening conditions such as hypogonadism or testicular cancer. Moreover, some causes of severe male factor infertility such as Y chromosome microdeletions and chromosomal translocations are genetically transmissible and may threaten the health or fertility of the patient’s potential offspring. Semen analysis should be performed according to standard protocol published by the World Health Organization (WHO). Each sample should be collected after an ejaculatory abstinence period of 2–5 days. Samples should be collected in wide-mouthed, sterile containers, maintained as close as possible to body temperature, and analyzed within 1 h. The semen sample is allowed to liquefy and is examined under wet mount light microscopy. The main parameters analyzed are ejaculate volume, pH, sperm concentration (sperm per mL), total sperm number (sperm per total ejaculate), sperm motility (% of sperm with any motility and % of sperm with forward progressive motility), and sperm morphology (% of morphologically normal sperm). Abnormalities of semen parameters are typically described using standard nomenclature (Table 1.1) based upon reference values published by the WHO (Table 1.2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Male Infertility Best Practice Policy Committee of the American Urological Association, Practice Committee of the American Society for Reproductive Medicine. Report on optimal evaluation of the infertile male. Fertil Steril. 2006;86(5 Suppl 1):S202–9.
Male Infertility Best Practice Policy Committee of the American Urological Association, Practice Committee of the American Society for Reproductive Medicine. Report on varicocele and infertility. Fertil Steril. 2004;82 Suppl 1:S142–5.
Practice Committee of American Society for Reproductive Medicine in collaboration with Society for Male Reproduction and Urology. The management of infertility due to obstructive azoospermia. Fertil Steril. 2008;90(5 Suppl):S121–4.
Showell MG, Brown J, Yazdani A, Stankiewicz MT, Hart RJ. Anti-oxidants for male subfertility. Cochrane Database Syst Rev. 2011;1(1):CD007411.
Sokol RZ. Endocrinology of male infertility: evaluation and treatment. Semin Reprod Med. 2009;27(2):149–58.
Stahl PJ, Stember DS, Schlegel PN. Interpretation of the semen analysis and initial male factor management. Clin Obstet Gynecol. 2011;54(4):656–65.
World Health Organization. WHO laboratory manual for the examination and processing of human semen. 5th ed. Geneva: World Health Organization; 2010.
Zini A, Boman JM. Varicocele: red flag or red herring? Semin Reprod Med. 2009;27(2):171–8.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mulhall, J.P., Stahl, P.J., Stember, D.S. (2014). Abnormal Semen Analysis. In: Clinical Care Pathways in Andrology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6693-2_1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6693-2_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6692-5
Online ISBN: 978-1-4614-6693-2
eBook Packages: MedicineMedicine (R0)